Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512181 · ClinicalTrials.gov registry record · NA
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
A NA study of Placenta Accreta Spectrum, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06512181 is a NA study of Placenta Accreta Spectrum that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06512181, a NA study of Placenta Accreta Spectrum, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.
Conditions Studied
Interventions
- OTHER Conservative/Expectant Management
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06512181
The ClinicalTrials.gov registry entry for NCT06512181 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Placenta Accreta Spectrum appearing as the primary indexed condition, and to 1 intervention - of which Conservative/Expectant Management is the first listed.
NCT06512181 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06512181 about?
NCT06512181 is a clinical study titled "Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders". This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative...
What is the current status of trial NCT06512181?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-04-21. Estimated completion is 2030-12-31.
What conditions does trial NCT06512181 study?
This clinical trial studies the following conditions: Placenta Accreta Spectrum.
What interventions are being tested in trial NCT06512181?
The interventions under investigation include: Conservative/Expectant Management (OTHER).
Who is sponsoring clinical trial NCT06512181?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06512181 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.